| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid:28772237 | ||||
| pmid:28774557 | ||||
| pmid:28805201 | ||||
| pmid:28814613 | ||||
| Choi EM et al. | Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. | 2017 | Environ. Toxicol. | pmid:28836330 |
| Tschiderer L et al. | Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. | 2017 | PLoS ONE | pmid:28837646 |
| Ozaki Y et al. | Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. | 2017 | PLoS ONE | pmid:28937990 |
| pmid:28957555 | ||||
| pmid:29025654 | ||||
| pmid:29050490 | ||||
| pmid:29121799 | ||||
| pmid:29253005 | ||||
| pmid:29262817 | ||||
| pmid:29313442 | ||||
| pmid:29348072 | ||||
| pmid:29402836 | ||||
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| pmid:29502401 | ||||
| Simonet WS et al. | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | 1997 | Cell | pmid:9108485 |
| Hofbauer LC and Heufelder AE | Osteoprotegerin: a novel local player in bone metabolism. | 1997 | Eur. J. Endocrinol. | pmid:9368500 |